Literature DB >> 24458279

The FIP1L1-PDGFRA fusion gene and the KIT D816V mutation are coexisting in a small subset of myeloid/lymphoid neoplasms with eosinophilia.

Annette Hildegard Schmitt-Graeff1, Philipp Erben, Juliane Schwaab, Beate Vollmer-Kary, Georgia Metzgeroth, Karl Sotlar, Hans-Peter Horny, Hans-H Kreipe, Paul Fisch, Andreas Reiter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24458279     DOI: 10.1182/blood-2013-10-530642

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Paratrabecular myelofibrosis and occult mastocytosis are strong morphological clues to suspect FIP1L1-PDGFRA translocation in hypereosinophilia.

Authors:  Sreejesh Sreedharanunni; Man Updesh Singh Sachdeva; Saniya Sharma; Sonia Rana; Rajeev Sandal; Narender Kumar; Prashant Sharma; Shano Naseem; Jasmina Ahluwalia; Reena Das; Pankaj Malhotra; Neelam Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2019-12-04       Impact factor: 0.900

Review 2.  The international consensus classification of mastocytosis and related entities.

Authors:  Roos J Leguit; Sa A Wang; Tracy I George; Alexandar Tzankov; Attilio Orazi
Journal:  Virchows Arch       Date:  2022-10-10       Impact factor: 4.535

3.  Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.

Authors:  Arianna Aricò; Serena Ferraresso; Silvia Bresolin; Laura Marconato; Stefano Comazzi; Geertruy Te Kronnie; Luca Aresu
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

Review 4.  Targeted Treatment Options in Mastocytosis.

Authors:  Mélanie Vaes; Fleur Samantha Benghiat; Olivier Hermine
Journal:  Front Med (Lausanne)       Date:  2017-07-20

Review 5.  The serum tryptase test: an emerging robust biomarker in clinical hematology.

Authors:  Peter Valent; Wolfgang R Sperr; Karl Sotlar; Andreas Reiter; Cem Akin; Jason Gotlib; Hans-Peter Horny; Michel Arock
Journal:  Expert Rev Hematol       Date:  2014-08-28       Impact factor: 2.929

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.